KINETIX
KINETIX develops 3D-printed scaffolds that act as local drug depots, holding drug-loaded material within their pores and releasing payloads into surrounding tissue over time. The scaffolds are computationally designed so architecture, material, and formulation work together to tune release profiles, with glioblastoma as the first research focus.
- New Materials
- Biotechnology
- Medical Devices
- Healthcare Technology
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
The drug can’t work if it can’t reach the target. Getting enough drug to the treatment site is a central delivery challenge, as biological barriers and distribution through the body can limit how much reaches the target.
Solution
KINETIX develops 3D-printed scaffolds that act as local drug depots, holding a drug-loaded material within their pores and releasing the payload into surrounding tissue over time. The scaffolds are computationally designed so that architecture, material, and formulation work together to tune the release profile at the treatment site. Two complementary loading routes accommodate a wide range of drugs: incorporation into the printed polymer itself or delivery through a drug-loaded hydrogel that fills and anchors within the pore network. The company studies how geometry, material, and loading affect release, comparing models with experimental measurements. A surface port connects to internal channels, allowing a fresh dose to be routed into the pore network to replenish the local depot after implantation.
Target Audience
Primary collaborators and potential customers are researchers and companies in drug formulation, biomaterials, and preclinical research focused on localized therapeutic delivery, with glioblastoma as the first application area.
Features
- Computationally designed 3D-printed scaffolds with tunable pore architecture for localized, sustained drug delivery
- Dual drug-loading routes: drug compounded into the printed polymer or delivered via a drug-loaded hydrogel filling the pore network
- Controlled-release engineering that integrates scaffold geometry, material properties, and formulation to tailor release kinetics
- Integrated reload channels and surface port designed to replenish the drug depot without scaffold removal
- Experimental validation comparing release models with measured drug transport from the scaffold into surrounding tissue